CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$433M
(+4.8%)
Cap. Flow
-$87.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
255
Reduced
393
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Karyopharm Therapeutics
KPTI
$57.2M
| $4.91M | 0.05% |
17,298
-39,060
| -69% | -$11.1M |
|
327
Dell
DELL
$84.4B
| $4.91M | 0.05% |
176,266
+150,445
| +583% | +$4.19M |
|
328
Pembina Pipeline
PBA
$22.1B
| $4.86M | 0.05% |
194,969
+21,672
| +13% | +$540K |
|
329
ConocoPhillips
COP
$116B
| $4.85M | 0.05% |
115,510
-4,325
| -4% | -$182K |
|
330
Domino's
DPZ
$15.7B
| $4.83M | 0.05% |
13,078
+10,171
| +350% | +$3.76M |
|
331
PVH
PVH
$4.22B
| $4.81M | 0.05% |
100,129
-30,918
| -24% | -$1.49M |
|
332
Baidu
BIDU
$35.1B
| $4.8M | 0.05% |
40,028
-145,429
| -78% | -$17.4M |
|
333
Adverum Biotechnologies
ADVM
$73.9M
| $4.77M | 0.05% |
22,858
+2,858
| +14% | +$597K |
|
|
ACIA
334
DELISTED
Acacia Communications, Inc. Common Stock
ACIA
| $4.73M | 0.05% |
+70,341
| New | +$4.73M |
|
335
Moody's
MCO
$89.5B
| $4.67M | 0.05% |
16,978
+535
| +3% | +$147K |
|
336
Quest Diagnostics
DGX
$20.5B
| $4.65M | 0.05% |
40,833
+6,553
| +19% | +$747K |
|
337
Royal Bank of Canada
RY
$204B
| $4.63M | 0.05% |
68,512
+2,240
| +3% | +$152K |
|
338
Micron Technology
MU
$147B
| $4.63M | 0.05% |
89,907
-18,455
| -17% | -$951K |
|
339
Consolidated Edison
ED
$35.4B
| $4.61M | 0.05% |
64,110
-97,133
| -60% | -$6.99M |
|
340
Manulife Financial
MFC
$52.1B
| $4.61M | 0.05% |
339,821
+43,940
| +15% | +$596K |
|
|
LOGM
341
DELISTED
LogMein, Inc.
LOGM
| $4.6M | 0.05% |
+54,213
| New | +$4.6M |
|
|
MYOV
342
DELISTED
Myovant Sciences Ltd.
MYOV
| $4.57M | 0.05% |
221,403
+97,742
| +79% | +$2.02M |
|
343
Darden Restaurants
DRI
$24.5B
| $4.54M | 0.05% |
59,854
-60,504
| -50% | -$4.58M |
|
|
NGM
344
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.52M | 0.05% |
228,764
-13,236
| -5% | -$261K |
|
345
GE Aerospace
GE
$296B
| $4.48M | 0.05% |
131,657
-19,748
| -13% | -$672K |
|
346
Hartford Financial Services
HIG
$37B
| $4.42M | 0.05% |
114,716
-88,852
| -44% | -$3.43M |
|
347
Zoetis
ZTS
$67.9B
| $4.42M | 0.05% |
32,245
-10,137
| -24% | -$1.39M |
|
348
Baxter International
BAX
$12.5B
| $4.42M | 0.05% |
51,314
-7,833
| -13% | -$674K |
|
349
Target
TGT
$42.3B
| $4.41M | 0.05% |
36,766
-52,763
| -59% | -$6.33M |
|
350
Illinois Tool Works
ITW
$77.6B
| $4.39M | 0.05% |
25,130
-8,485
| -25% | -$1.48M |
|